Related Experiment Video
Updated: Apr 22, 2026

Author Spotlight: Advancing the Analysis of Plasma Extracellular Vesicle Proteome for Cardiovascular Biomarker Studies
Published on: January 31, 2025
[Discrete plasmapheresis for coronary heart disease]
Aim:
To provide a rationale for the expediency and efficiency of discrete plasmapheresis (PA) in the package of therapeutic measures for coronary heart disease (CHD).
Subjects And Methods:
585 sessions or 120 cycles of low-volume therapeutic PA were performed in 91 patients with CHD. The parameters of blood lipid composition, hemocoagulation, rheology, and endotoxicosis were studied.
Results:
Removal of 100% circulating plasma volume per treatment cycle could achieve a significant positive result of abnormally higher homeostatic parameters. The levels of high-density lipoprotein cholesterol, antithrombin III, and albumin did not decrease significantly.
Conclusion:
Low-volume discrete PA is a pathogenetically sound and effective method to affect homeostasis in CHD.
Related Concept Videos
Coronary Artery Disease V: Interprofessional Care
Extracorporeal Removal of Drugs: Hemoperfusion and Hemofiltration
Extracorporeal Removal of Drugs: Continuous Renal Replacement Therapy
Acute Coronary Syndrome IV: Interprofessional Care
Extracorporeal Removal of Drugs: Peritoneal Dialysis and Hemodialysis
Cardiomyopathy II: Dilated Cardiomyopathy

